bisbenzimidazole has been researched along with 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YQ; Clyman, RI; Koch, C; Lin, E; Mauray, F; Oprysko, PR; Seidner, SR; Tse, MM | 1 |
1 other study(ies) available for bisbenzimidazole and 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide
| Article | Year |
|---|---|
Combined prostaglandin and nitric oxide inhibition produces anatomic remodeling and closure of the ductus arteriosus in the premature newborn baboon.
Topics: Animals; Animals, Newborn; Bisbenzimidazole; Blood Pressure; Cardiovascular Agents; DNA Fragmentation; Ductus Arteriosus; Endothelial Growth Factors; Enzyme Inhibitors; Etanidazole; Fetus; Fluorescent Dyes; Hydrocarbons, Fluorinated; Hypoxia; Immunohistochemistry; In Situ Nick-End Labeling; Indicators and Reagents; Indomethacin; Lymphokines; Nitric Oxide; Nitroarginine; Papio; Prostaglandins; Respiratory Physiological Phenomena; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |